Male patient whose sexual partner(s) are women of child bearing potential, who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partners are WOCBP not using a double method of contraception during the study and  months after the end of treatment. One of these methods must be a condom
Male patients whose sexual partner(s) are WCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patient whose sexual partner(s) are women of childbearing potential who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partners are WOCBP not using a double method of contraception during the study and  months after the end of treatment; one of these methods must be a condom
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Has male sexual partner with vasectomy
Male patient whose sexual partner(s) are women of childbearing potential (WOCBP) who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP must agree to use adequate contraception as defined above during the study and for  weeks after the end of treatment; condom use is required by all male patients in order to prevent delivery of the drug via seminal fluid
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are women of childbearing potential must agree to use adequate contraception during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  months after the end of treatment (male patients must use highly effective [double barrier] methods of contraception [e.g., spermicidal gel plus condom] for the entire duration of the study, and continuing using contraception and refrain from fathering a child for  months following the study drug; a condom is required to be used also by vasectomized men as well as during intercourse with a male partner in order to prevent delivery of the study treatment via seminal fluid)
Male patient whose sexual partner(s) are women of childbearing potential (WOCBP) who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patient whose sexual partner(s) are women of childbearing potential (WOCBP) who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
EXPANSION COHORT ONLY: Male patients whose sexual partner(s) are women of child-bearing potential (WOCBP) who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patient whose sexual partner(s) are women of childbearing potential (WOCBP) who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patient whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
Male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception, during the study and for  weeks after the end of treatment
